Publication pre-print: A novel fully automated system for lifelong continuous phenotyping of mouse cognition and behaviour

July 1, 2022

Dr Marco Brancaccio and Dr Julija Krupic were awarded funding in Stage I of the Key Questions funding programme with the Project: Lost in space and (circadian) time: Investigating the role of disrupted deep brain circuitry in diminished spatial memory function in Alzheimer’s disease

Cambridge Phenotyping presents a new fully automated AI-driven home-cage system for cognitive and behavioural phenotyping in mice. The system incorporates spontaneous alternation T-maze, novel-object recognition and object-in-place recognition tests combined with monitoring of an animal position, water consumption, quiescence and locomotion patterns, all carried out continuously and simultaneously in an unsupervised fashion over long periods of time. Mice learnt the tasks rapidly without any need for water or food restrictions.

Read the pre-print

transforming pre-clinical and basic science research on cognition and behaviour

EMAIL US

New UK DRI scheme launched to fund bold and boundary pushing research

May 17, 2024

Our Smart Kages are paying a vital role to enable the research ideas of the future.

uncovering the earliest signs of Alzheimer’s disease

Mar 29, 2024

The entorhinal cortex and hippocampus, regions in the brain’s medial temporal lobe, are the first to exhibit neurodegeneration in Alzheimer’s. Work pioneered by Nobel Laureate Prof John O’Keefe (UK DRI Associate Member at UCL) has identified that neurons in these...

Cambridge Phenotyping Awarded for Innovative Solutions

Dec 1, 2023

Cambridge Phenotyping was recently nominated and won the ‘Investment into Innovative Solutions’ award at the 15th annual European Sails 2023 event!

Best Emerging Tech nomination

Nov 22, 2022

Cambridge Phenotyping has been nominated for the Best Emerging Tech Award by the Vilnius TechFusion Startup Awards 2022

Cambridge Phenotyping attracts 610K EUR investment

May 5, 2022

Coinvest, the acceleration fund 70V and business angels invest in Cambridge Phenotyping, a company founded by neuroscientists Julija Krupic and Marius Bauza.

From UK Dementia Research Institute

May 4, 2022

Just imagine that you have your mouse, which has received no training. You put it in the cage, close it up and walk away, that is it. The system does all the testing for you, 24/7, with the data put out in near real time so you can run all the analysis that same day.